Mentari Therapeutics, Inc. (MTRI)
$18.60+1.36%Close
Snapshot
- 1 week
- +19.5%+16.9% vs SPY
- 1 month
- +39.8%+42.9% vs SPY
- Market cap
- $6.8B
- P/E
- negindustry 14.9
- P/B
- -8.5
- EV/EBITDA
- 116.4
- FCF yield
- -88.4%
- Consensus
- Buy2 buy · 0 hold · 0 sell
- Price target
- $30.00+61.3% upside
Signal evidence
Prediction markets
… linked markets on Kalshi and Polymarket.
Loading markets…
Company
Healthcare · Biotechnology · CEO Gregory J. Divis
About
Mentari Therapeutics, Inc. (MTRI). Mentari Therapeutics, Inc. is a biotechnology company, which engages in developing therapies for migraine prevention. Its portfolio includes MT-001 and MT-002. The company was founded on June 13, 2025 and is headquartered in Waltham, MA.
SEC filingsCIK 1728328
Profile
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
CountryUS
CEOGregory J. Divis
IPOMay 5, 2014
Employees6
Shares outstanding368.3M
Float0
Free float0.0%
Websitementaritx.com
Key executives
- Thomas W. WelchChairman & Chief Executive Officer
- Michael D. WelchPres and Director
- Alex SolomonovicChief Scientific Officer and Vice President
Snapshot
Price & returns1 month +39.8%
- 1 week
- +19.5%+16.9% vs SPY
- 1 month
- +39.8%+42.9% vs SPY
ValuationP/E neg vs industry 14.9 · market cap $6.8B
- Market cap
- $6.8B
- P/E
- negindustry 14.9
- P/B
- -8.5
- EV/EBITDA
- 116.4
- FCF yield
- -88.4%
Street & earningsTarget $30.00 (+61.3% upside)2 buy · 0 hold · 0 sell
- Consensus
- Buy2 buy · 0 hold · 0 sell
- Price target
- $30.00+61.3% upside
Signal evidence
Prediction markets
… linked markets on Kalshi and Polymarket.
Loading markets…
Company
Healthcare · Biotechnology · CEO Gregory J. Divis
About
Mentari Therapeutics, Inc. (MTRI). Mentari Therapeutics, Inc. is a biotechnology company, which engages in developing therapies for migraine prevention. Its portfolio includes MT-001 and MT-002. The company was founded on June 13, 2025 and is headquartered in Waltham, MA.
SEC filingsCIK 1728328
Profile
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
CountryUS
CEOGregory J. Divis
IPOMay 5, 2014
Employees6
Shares outstanding368.3M
Float0
Free float0.0%
Websitementaritx.com
Key executives
- Thomas W. WelchChairman & Chief Executive Officer
- Michael D. WelchPres and Director
- Alex SolomonovicChief Scientific Officer and Vice President
Fundamentals
Scores & profile
FUND, Value, Growth and GARP scores and the archetype
ROIC-182.1%
Revenue YoY-
ROE-303.5%
EPS YoY-
ROA-
Valuation
P/E (TTM)-0.60
P/E (forward)-
Sector P/E20.81
Industry P/E14.93
P/B-8.48
P/FCF-
EV/EBITDA116.44
EV/EBIT-
FCF yield-88.44%
True FCF yield-1985.84%
PEG-
Buyback yield0.00%
Risk
Interest cover-949.5×
Debt/equity-
Altman Z1409.96
Current ratio0.50
Net debt/EBITDA-
INTEREST COVERAGE < 1.5X (-949.47X)NET INCOME (TTM) < 0
Fundamentals
Scores & profile
FUND, Value, Growth and GARP scores and the archetype
ROIC-182.1%
Revenue YoY-
ROE-303.5%
EPS YoY-
ROA-
Valuation
P/E (TTM)-0.60
P/E (forward)-
Sector P/E20.81
Industry P/E14.93
P/B-8.48
P/FCF-
EV/EBITDA116.44
EV/EBIT-
FCF yield-88.44%
True FCF yield-1985.84%
PEG-
Buyback yield0.00%
Risk
Interest cover-949.5×
Debt/equity-
Altman Z1409.96
Current ratio0.50
Net debt/EBITDA-
INTEREST COVERAGE < 1.5X (-949.47X)NET INCOME (TTM) < 0
